phase readout

NCT05613088: A Study of MORAb-202 Versus Investigator's Choice Chemotherapy in Female Participants With Platinum-resistant High-grade Serous (HGS) Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

COMPLETEDupdated 2mo ago

community read0 votes

Sponsor: Bristol-Myers Squibb. Phase: PHASE2. Conditions: Neoplasms, Ovarian

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

last refreshed 1h ago

Found something off?